Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Adaptive Biotechnologies Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $276.98M | $178.96M | $170.28M | $185.31M | $154.34M | $98.38M | $85.07M | $55.66M | $38.45M |
| Revenue Growth? | +54.8% | +5.1% | -8.1% | +20.1% | +56.9% | +15.6% | +52.8% | +44.8% | 0.0% |
| Cost of Revenue? | $71.36M | $72.08M | $75.55M | $57.91M | $49.30M | $22.53M | $22.27M | $19.67M | $15.68M |
| Gross Profit? | $205.62M | $106.88M | $94.72M | $127.40M | $105.04M | $75.85M | $62.80M | $35.99M | $22.77M |
| Gross Margin? | +74.2% | +59.7% | +55.6% | +68.7% | +68.1% | +77.1% | +73.8% | +64.7% | +59.2% |
| Operating Expenses? | $262.74M | $269.43M | $321.76M | $327.58M | $314.01M | $228.67M | $141.19M | $85.75M | $66.40M |
| Operating Income? | -$57.12M | -$162.55M | -$227.03M | -$200.19M | -$208.97M | -$152.82M | -$78.39M | -$49.76M | -$44.48M |
| EBITDA? | -$29.85M | -$128.76M | -$189.27M | -$175.21M | -$193.34M | -$144.34M | -$70.60M | -$43.76M | -$37.84M |
| Income Before Tax | -$59.46M | -$159.59M | -$225.30M | -$200.37M | -$207.30M | -$146.23M | -$68.61M | -$46.45M | -$42.83M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$59.50M | -$159.49M | -$225.25M | -$200.19M | -$207.28M | -$146.23M | -$68.61M | -$46.45M | -$42.83M |
| EPS? | $-0.39 | $-1.08 | $-1.56 | $-1.00 | $-1.46 | $-1.06 | $-0.47 | $-0.44 | $-0.41 |
| Diluted EPS? | $-0.39 | $-1.08 | $-1.56 | $-1.00 | $-1.46 | $-1.06 | $-0.47 | $-0.44 | $-0.41 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality